Drug and alcohol testing of women who are pregnant or who want to become pregnant is a resource for physicians to help prevent complications for the woman and the fetus during the gestational period.
During preconception counseling, women are advised about the risks of alcohol, tobacco and drug use to the fetus. Screening for substance use provides a tool for physicians so that the patient can be assessed and referred for treatment before becoming pregnant.
Screening and assessment of a pregnant woman can identify substance abuse early enough for intervention, allowing for prevention or at least preparation for serious problems for the fetus or neonate. Quantitative drug testing provides an additional component in assessing the comprehensive picture of a patient’s health. By reporting exact measurements of drugs in the system, drug testing not only helps in protecting the overall health and well-being of present and future mothers, but also detects important drug to drug interactions.
Additionally, known complications of substance abuse like Fetal Alcohol Syndrome or placental abruption resulting from cocaine use can be detected early, and life-saving treatment and counseling can be initiated.
Patient education with a clear treatment plan makes the process much easier and increases the chances of having a healthy baby and a healthy mother. Women’s healthcare professionals make it their mission to assist in quality patient care for those who are planning to get pregnant, who are already pregnant, or those who are postpartum. Spectra Clinical Labs values our relationship with women’s healthcare professionals, and we are dedicated to providing them with our best service.